January 7, 2022
BioWorld highlights JelikaLite’s breakthrough device designation status from the FDA in their featured article.
Learn More

One thought on “BioWorld highlights JelikaLite’s breakthrough device designation status from the FDA in their featured article.

Leave a Reply

Your email address will not be published. Required fields are marked *